Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Miriam Kozárová
Observed names:
M Kozarova,
M Kozárová,
M. KOZAROVA,
M. KOZÁROVÁ,
M. Kozarova,
M. Kozárová,
Miriam KOZAROVA,
Miriam Kozarova
show all 8
Institutions:
University of Pavol Jozef Šafárik,
Univerzitná Nemocnica Louisa Pasteura
Observed institutions:
University of Pavol Jozef Šafárik,
Univerzitná Nemocnica Louisa Pasteura,
European Atherosclerosis Society
ORCID:
0000-0001-5596-8965
Observed ORCID:
0000-0001-5596-8965
OpenAlex ID:
A5048064496
Works
45
Awards
1
Global perspective of familial hypercholesterolaemia: a cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC)
2021
·
Antonio J. Vallejo-Vaz
, Christophe A.T. Stevens
, et al.
·
The Lancet
·
374
Familial hypercholesterolaemia in children and adolescents from 48 countries: a cross-sectional study
2023
·
Kanika Inamdar Dharmayat
, Antonio J. Vallejo-Vaz
, et al.
·
The Lancet
·
109
PDF
KCNJ11 gene E23K variant and therapeutic response to sulfonylureas
2011
·
Martin Javorsky
, Lucia Klimcakova
, et al.
·
European Journal of Internal Medicine
·
98
Effect of sulphonylurea treatment on glycaemic control is related to TCF7L2 genotype in patients with type 2 diabetes
2010
·
Z. Schroner
, M. Javorsky
, et al.
·
Diabetes Obesity and Metabolism
·
77
Variation in KCNQ1 is associated with therapeutic response to sulphonylureas
2011
·
Zbynek Schroner
, Martina Dobrikova
, et al.
·
Medical Science Monitor
·
39
PDF
Effect of gene polymorphisms on lipoprotein levels in patients with dyslipidemia of metabolic syndrome
2006
·
A Stančáková
, L Baldaufová
, et al.
·
Physiological Research
·
30
PDF
KCNQ1 gene polymorphism is associated with glycaemic response to treatment with DPP-4 inhibitors
2017
·
Ivana Gotthardová
, Martin Javorský
, et al.
·
Diabetes Research and Clinical Practice
·
27
Variation in CDKAL1 Gene Is Associated With Therapeutic Response to Sulphonylureas
2012
·
Z. SCHRONER
, M. JAVORSKÝ
, et al.
·
Physiological Research
·
23
PDF
Association of BMI, lipid-lowering medication, and age with prevalence of type 2 diabetes in adults with heterozygous familial hypercholesterolaemia: a worldwide cross-sectional study
2024
·
Amany Elshorbagy
, Alexander R.M. Lyons
, et al.
·
The Lancet Diabetes & Endocrinology
·
21
Fenofibrate treatment reduces circulating conjugated diene level and increases glutathione peroxidase activity
2006
·
Ivan Tkáč
, Angela Molčányiová
, et al.
·
Pharmacological Research
·
21
Osteoprotegerin concentration is associated with the presence and severity of peripheral arterial disease in type 2 diabetes mellitus
2018
·
Katarína Demková
, Miriam Kozárová
, et al.
·
VASA
·
20
Serotonin transporter 5-HTTLPR polymorphism and escitalopram treatment response in patients with major depressive disorder
2024
·
Dominika Jarčušková
, Ivan Tkáč
, et al.
·
BMC Psychiatry
·
18
PDF
Circulating Lipopolysaccharide-Binding Protein and Carotid Intima-Media Thickness in Obstructive Sleep Apnea
2018
·
I. TROJOVA
, M. KOZAROVA
, et al.
·
Physiological Research
·
13
PDF
The Molecular Genetic Background of Familial Hypercholesterolemia: Data From the Slovak Nation-Wide Survey
2017
·
D. GABČOVÁ
, B. VOHNOUT
, et al.
·
Physiological Research
·
13
PDF
Lipoprotein (a) concentration as a risk factor for ischaemic stroke and its subtypes
2024
·
Antonia Lackova
, Zuzana Gdovinova
, et al.
·
Neurologia i Neurochirurgia Polska
·
11
PDF
Pharmacogenetics of oral antidiabetic treatment
2011
·
Z Schroner
, M Javorsky
, et al.
·
Bratislavské lekárske listy/Bratislava medical journal
·
11
Relationship among urinary albumin excretion rate, lipoprotein lipase PvuII polymorphism and plasma fibrinogen in type 2 diabetic patients
2006
·
M Javorský
, M Kozárová
, et al.
·
Physiological Research
·
11
PDF
Interaction between angiotensin-converting enzyme genotype and glycaemic control influences lipoprotein levels in Type 2 diabetes mellitus
2003
·
Ivan Tkáč
, Ján Šalagovič
, et al.
·
Wiener klinische Wochenschrift
·
10
Treatment pattern of familial hypercholesterolemia in Slovakia: Targets, treatment and obstacles in common practice
2018
·
Branislav Vohnout
, Ľubomíra Fábryová
, et al.
·
Atherosclerosis
·
9
Decreased 25-Hydroxy Vitamin D Level Is Associated with All-Cause Mortality in Patients with Type 2 Diabetes at High Cardiovascular Risk
2023
·
Alena Stančáková Yaluri
, Ivan Tkáč
, et al.
·
Metabolites
·
8
PDF
Relationship of five type 2 diabetes candidate gene polymorphisms to the age at diagnosis of diabetes in the Slovakian population
2010
·
M Kozarova
, M Javorsky
, et al.
·
Bratislavské lekárske listy/Bratislava medical journal
·
7
PDF
Angiotensin-converting enzyme genotype, albuminuria and plasma fibrinogen in type 2 diabetes mellitus
2003
·
Ivan Tkáč
, Ján Šalagovič
, et al.
·
Wiener klinische Wochenschrift
·
6
Lipoprotein (a): A Novel Cardiovascular Risk Factor
2023
·
Miriam Kozarova
, Antonia Lackova
, et al.
·
Balkan Medical Journal
·
4
PDF
Th-P16:305 Fenofibrate treatment reduces circulating conjugated diene level and increases glutathione peroxidase activity
2006
·
I. Tkac
, A. Molcanyiova
, et al.
·
Atherosclerosis Supplements
·
4
Osteoprotegerin concentration is associated with presence and severity of peripheral arterial disease in type 2 diabetes mellitus
2018
·
M. Kozarova
, K. Demkova
, et al.
·
Atherosclerosis
·
3
Show more works
View as search
Works count:
45
Citation count:
982
H-index:
13
I10-index:
18
Year
Topic
Type